Merck & Co., Inc. Stockholders' Equity 2006-2026 | MRK
What is stockholders' equity?
Stockholders' equity can be defined as total assets minus total liabilities, representing the owners' residual interest in the company after all debts are paid.
What is Merck & Co., Inc.'s current stockholders' equity?
Merck & Co., Inc. (MRK) annual stockholders' equity for 2025 was $52.66B, a 13.56% increase from 2024. Merck & Co., Inc. stockholders' equity for the quarter ending March 31, 2026 was $45.93B.
What was Merck & Co., Inc.'s stockholders' equity in 2024?
Merck & Co., Inc. annual stockholders' equity for 2024 was $46.37B, a 23.22% increase from 2023.
What was Merck & Co., Inc.'s stockholders' equity in 2023?
Merck & Co., Inc. annual stockholders' equity for 2023 was $37.63B, a 18.29% decline from 2022.
What is Merck & Co., Inc.'s 5-year stockholders' equity CAGR?
Merck & Co., Inc. stockholders' equity grew at a compound annual growth rate (CAGR) of 15.70% from FY2020 to FY2025, going from $25.40B to $52.66B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $52.66B | +13.6% | 10-K |
| FY2024 | $46.37B | +23.2% | 10-K |
| FY2023 | $37.63B | -18.3% | 10-K |
| FY2022 | $46.06B | +20.4% | 10-K |
| FY2021 | $38.26B | +50.6% | 10-K |
| FY2020 | $25.40B | -2.3% | 10-K |
| FY2019 | $26.00B | -3.3% | 10-K |
| FY2018 | $26.88B | -22.2% | 10-K |
| FY2017 | $34.57B | -14.2% | 10-K |
| FY2016 | $40.31B | -10.0% | 10-K |
| FY2015 | $44.77B | -8.2% | 10-K |
| FY2014 | $48.79B | -6.8% | 10-K |
| FY2013 | $52.33B | -5.7% | 10-K |
| FY2012 | $55.46B | -2.6% | 10-K |
| FY2011 | $56.94B | +0.2% | 10-K |
| FY2010 | $56.80B | -7.6% | 10-K |
| FY2009 | $61.48B | +190.5% | 10-K |
| FY2008 | $21.17B | +2.8% | 10-K |
| FY2007 | $20.59B | +3.1% | 10-K |
| FY2006 | $19.97B | - | 10-K |